Kangmei Pharma | 600518 - Debt

Stock Price
1.71
Daily Change
0 0%
Monthly
-2.84%
Yearly
-10.94%
Q2 Forecast
1.69

Kangmei Pharma reported CNY131.64M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Genomma Lab Internacional MXN 8.06B 488.83M Mar/2026
Hypermarcas BRL 8.86B 535.71M Jun/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Jiangsu Hengrui CNY 74.23M 17.2M Dec/2025
Kangmei Pharma CNY 131.64M 90.18M Jun/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Sh Fosun Pharma CNY 36.99B 176.57M Jun/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.41B 25.6M Dec/2025
Wuxi Apptec CNY 8.42B 904.01M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 52.69M Jun/2025